Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to use functional Magnetic Resonance Imaging (fMRI) to measure
neural reactivity to alcohol-related and emotional cues in alcohol dependent subjects
following a single dose of the opioid receptor modulator nalmefene. The study will be done in
a cross over design with nalmefene versus placebo.